During the past decade, Centro de Referencia E Treinamento Dst/Aids conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centro de Referencia E Treinamento Dst/Aids" #1 sponsor was "Janssen Vaccines & Prevention B.V." with 4 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 3 trials sponsored, "Gilead Sciences" with 1 trials sponsored, "Oswaldo Cruz Foundation" with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centro de Referencia E Treinamento Dst/Aids" #1 collaborator was "ANRS, Emerging Infectious Diseases" with 1 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Centro de Referência e Treinamento DST AIDS" with 1 trials as a collaborator and "Copenhagen HIV Programme (CHIP) -- Copenhagen, Denmark" with 1 trials as a collaborator. Other collaborators include 15 different institutions and companies that were collaborators in the rest 25 trials.

According to Clinical.Site data, the most researched conditions in "Centro de Referencia E Treinamento Dst/Aids" are "HIV Infections" (4 trials), "AIDS" (1 trials), "COVID-19 Prevention" (1 trials), "HIV" (1 trials) and "HIV Infection" (1 trials). Many other conditions were trialed in "Centro de Referencia E Treinamento Dst/Aids" in a lesser frequency.

Most popular intervention types in "Centro de Referencia E Treinamento Dst/Aids" are "Biological" (7 trials), "Drug" (5 trials), "Other" (3 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ad26.COV2.S" (3 trials), "Placebo" (3 trials), "Ad26.Mos4.HIV" (1 trials), "All licensed antiretroviral medications" (1 trials) and "Clade C and Mosaic gp140 HIV bivalent vaccine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centro de Referencia E Treinamento Dst/Aids" are 12 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Centro de Referencia E Treinamento Dst/Aids". undefined are not yet recruiting, 1 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Centro de Referencia E Treinamento Dst/Aids, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Centro de Referencia E Treinamento Dst/Aids, 2 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".